TMEM106B and lung cancer: Based on our findings we propose a model by which elevated levels of TMEM106B in primary lung cancers lead to an increased nuclear translocation of TFEB. This results in a TFEB-dependent upregulation of lysosome genes of the CLEAR pathway, which are loaded in enlarged vesicular lysosomes.